Sanofi Appoints Hugo Fry as General Manager UK

GUILDFORD, England, February 1, 2017 /PRNewswire/ --

- Dr Hubert Bland appointed as UK Medical Chair and Medical Head of Diabetes and Cardiovascular for UK &Ireland - 

Sanofi today announces the appointment of Hugo Fry as General Manager for the UK and General Manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert Bland as UK Medical Chair and Medical Head of Diabetes and Cardiovascular for the UK & Ireland.

     (Logo: http://mma.prnewswire.com/media/463432/Sanofi_Logo.jpg )

     (Photo: http://mma.prnewswire.com/media/463431/Sanofi_Hugo_Fry.jpg )
     (Photo: http://mma.prnewswire.com/media/463430/Sanofi_Hubert_Bland.jpg )

Commenting on his appointment, Hugo Fry said: "Iamhonouredtobe appointed as General Managerfor theUK.I am proud and motivated to leadour more than1,800UKcolleagues, who continuously demonstrate their commitment to serving the people whose lives we touch.Our ambitionin the UKis tobea partnerin improving the nation's health.We are dedicated to leveraging theunique diversityof our portfolio and strength of our pipeline toempower people to live life to the fullest."

Hubert Bland added: "The UK healthcare system is under constant pressure therefore thedemand for new and effectivetreatments, services andsolutionsis ever-increasing. An effective medical function within Sanofi is vital to ensurewe are there for people in the moments that matter. Iamcommittedto leading a teamthatfunctions at the highestlevel ofquality standardsand adds significant value to healthcare professionals andother relevant stakeholders on behalf of Sanofi in the UK."

Hugo has over 20 years of experience in the pharmaceutical industry and has held various Global and regional management, commercial and strategic roles. Prior to assuming this role, Hugo was the Chief Marketing Officer for Sanofi Pasteur MSD (SPMSD), leading the commercial effort for the European Vaccine Joint Venture. He brings a wealth of experience in commercial leadership, and delivering growth and driving performance in healthcare.

Hubert joins Sanofi from TMC Pharma, where he held the role of Vice President of Medical since 2013. Prior to this, he held medical leadership positions at Pfizer, Boehringer-Ingelheim, Linde and the University of Surrey's Clinical Research Centre. Hubert graduated from the University of Cape Town Medical School in 1991, and thereafter spent nine years training and practising in Internal Medicine, Anaesthetics, Intensive Care and Exercise Medicine in the UK before joining the pharmaceutical industry.  He maintains his licence to practise medicine and is currently an Educational Supervisor and Member of the Faculty of Pharmaceutical Physicians.

About Sanofi 

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organised into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).